Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association of Apelin Levels in Overweight-obese Children with Pubertal Development, but Not with Insulin Sensitivity: 6.5 Years Follow up Evaluation.
Sentinelli F, Bertoccini L, Incani M, Pani MG, David F, Bailett D, Boi A, Barchetta I, Cimini FA, Mannino AC, Lenzi A, Cavallo MG, Loche S, Cossu E, Baroni MG. Sentinelli F, et al. Among authors: bertoccini l. Endocr Res. 2020 Nov;45(4):233-240. doi: 10.1080/07435800.2020.1804929. Epub 2020 Aug 13. Endocr Res. 2020. PMID: 32791927
The vitamin D receptor (VDR) gene rs11568820 variant is associated with type 2 diabetes and impaired insulin secretion in Italian adult subjects, and associates with increased cardio-metabolic risk in children.
Sentinelli F, Bertoccini L, Barchetta I, Capoccia D, Incani M, Pani MG, Loche S, Angelico F, Arca M, Morini S, Manconi E, Lenzi A, Cossu E, Leonetti F, Baroni MG, Cavallo MG. Sentinelli F, et al. Among authors: bertoccini l. Nutr Metab Cardiovasc Dis. 2016 May;26(5):407-13. doi: 10.1016/j.numecd.2016.02.004. Epub 2016 Feb 19. Nutr Metab Cardiovasc Dis. 2016. PMID: 27052925
No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
Barchetta I, Del Ben M, Angelico F, Di Martino M, Fraioli A, La Torre G, Saulle R, Perri L, Morini S, Tiberti C, Bertoccini L, Cimini FA, Panimolle F, Catalano C, Baroni MG, Cavallo MG. Barchetta I, et al. Among authors: bertoccini l. BMC Med. 2016 Jun 29;14:92. doi: 10.1186/s12916-016-0638-y. BMC Med. 2016. PMID: 27353492 Free PMC article. Clinical Trial.
WISP1 Is a Marker of Systemic and Adipose Tissue Inflammation in Dysmetabolic Subjects With or Without Type 2 Diabetes.
Barchetta I, Cimini FA, Capoccia D, De Gioannis R, Porzia A, Mainiero F, Di Martino M, Bertoccini L, De Bernardinis M, Leonetti F, Baroni MG, Lenzi A, Cavallo MG. Barchetta I, et al. Among authors: bertoccini l. J Endocr Soc. 2017 Apr 18;1(6):660-670. doi: 10.1210/js.2017-00108. eCollection 2017 Jun 1. J Endocr Soc. 2017. PMID: 29264519 Free PMC article.
Greater circulating DPP4 activity is associated with impaired flow-mediated dilatation in adults with type 2 diabetes mellitus.
Barchetta I, Ciccarelli G, Barone E, Cimini FA, Ceccarelli V, Bertoccini L, Sentinelli F, Tramutola A, Del Ben M, Angelico F, Baroni MG, Lenzi A, Cavallo MG. Barchetta I, et al. Among authors: bertoccini l. Nutr Metab Cardiovasc Dis. 2019 Oct;29(10):1087-1094. doi: 10.1016/j.numecd.2019.07.010. Epub 2019 Jul 23. Nutr Metab Cardiovasc Dis. 2019. PMID: 31431395
40 results